References
- Moldenhauer F., David J., Fielder A. H. L., Lachmann P. J., Walport M. J. Inherited deficiency of erythrocyte complement receptor type 1 does not cause susceptibility to systemic lupus erythematosus. Arthritis Rheum 1987; 30: 961–966
- Cohen J. H. M, Lutz H. U., Pennaforte J. L., Kazatchkine M. D. Peripheral catabolism of CR1 (the C3b receptor, CD35) on erythrocytes from healthy individuals and patients with systemic lupus erythematosus (SLE). Clin. exp. Immunol 1992; 87: 422–428
- Schifferli J. A., Ng Y. C, Peters D. K. The role of complement and its receptor in the elimination of immune complexes. N. Engl. J. Med 1986; 315: 488–495
- Hebert L. A., Cosio F. G. The erythrocyte-immune complex-glomerulonephritis connection in man. Kidney Int 1987; 31: 877–885
- Schifferli J. A., Ng Y. C, Estreicher J., Nalport M. J. The role of hypocomplementaemia and low erythrocyte complement receptor 1 numbers in determining abnormal immune complex clearance in humans. Clin. exp. Immunol 1989; 35: 993–1003
- Walport M. J., Lachmann P. J. Complement deficiencies and abnormalities of complement system in systemic lupus erythematosus and related disorders. Curr. Opin. Rheumatol 1990; 2: 661–663
- Clark W. F., Dan P. C, Euler H. H., Guillevin L., Harsford J., Heer A. H. Plasmapheresis and subsequent pulse cyclophosphamide versus pulse cyclophosphamide alone in severe lupus; design of the LPSG trial. J. Clin. Apheresis 1991; 6: 40–47
- Pohl M. A., Lan S. P., Berl T. Plasmapheresis does not increase the risk for infection in immunosuppressed patients with severe lupus nephritis. Ann. Intern. Med 1991; 114: 924–929
- Tan E. M., Cohen A. S., Fries J. F., Masi A. T., McShane D. J., Rothfield N. F. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271–1277
- Cornillet P., Philbert F., Kazatchkine M. D., Cohen J. H. M. Genomic determination of the CR1 (CD35) density polymorphism on erythrocytes using polymerase chain reaction amplification and Hindlll restriction enzyme digestion. J. Immunol. Methods 1991; 136: 193–197
- Bambardieri C, Hadman D. D., Urowitz M. B., Caron D., Chang C. H. and Committee on Prognosis Studies in SLE: Derivation of the SLE DAI. A disease activity index for lupus patients. Arthritis and Rheum 1992; 35: 630–640
- Dan P. C, Callahan J., Parker R., Globus J. Immunologic effects of plasmapheresis synchronized with pulse cyclophosphamide in systemic lupus erythematosus. J. Rheumatol 1991; 18: 270–276
- Füst Gy., Kávai M., Szegedi Gy., Merétey K., Falus A., Lenkey Á. Evaluation of different methods for detecting circulating immune complexes. An interlaboratory study. J. Immunol. Methods 1980; 38: 281–289
- Jepsen H. H., Svehag S-E., Jarlbaek L., Baatrup G. Interaction of complement-solubilized immune complexes with CR1 receptors on human erythrocytes. The binding reaction. Scand. J. Immunol 1986; 23: 65–73
- Schneider M., Berning T., Waldendorg M., Glaser J., Gerlach U. Immunosorbent plasma perfusion in patients with systemic lupus erythematosus. J Rheumatol 1990; 17: 900–907
- Fan Q., Uring-Lambert B., Weill B., Gautreau C, Menkes C. J., Delpech M. Complement component C4 deficiencies and gene alterations in patients with systemic lupus erythematosus. Eur. J. Immunogenet 1993; 1: 11–21
- Huber C, Rüger A, Herrmann M., Krapf F., Kalden J. R. C3-containing immune complexes in patients with systemic lupus erythematosus: correlation to disease activity and comparison with other rheumatic diseases. Rheumatol. Int 1989; 9: 59–64
- Möller-Rasmussen J., Jepsen H. H., Teisner B., Holmskov-Nielsen U., Rasmussen G. G., Svehag S-E. Quantification by ELISA of erythrocyte-bound C3 fragments expressing C3d and/or C3c epitopes in patients with factor I deficiency and with autoimmune diseases. Vox Sang 1989; 56: 262–269
- Kávai M., Möller-Rasmussen J., Baatrup G., Zsindely A., Svehag S-E. Inefficient binding of IgM immune complex to erythrocyte C3b-C4b receptors (CR1) and weak incorporation of C3b-iC3b into the complex. Scand. J. Immunol 1988; 28: 123–128